Greenway Greenhouse Cannabis Corp.

As of June 30, 2026, Greenway Greenhouse Cannabis Corporation carries a market capitalization of 13.62M, placing it among publicly traded companies globally. Its enterprise value stands at 23.76M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Greenway Greenhouse Cannabis Corporation has 133.60M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.38, and the price-to-book ratio stands at 2.71.

These figures are as of June 30, 2026. The EV/Sales ratio of 4.18 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 23.76M versus a market cap of 13.62M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Greenway Greenhouse Cannabis Corporation maintains a current ratio of 0.46, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 217.48, indicating elevated leverage, while an interest coverage ratio of -0.05 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Greenway Greenhouse Cannabis Corporation posted a negative return on equity (ROE) of -35.79, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -9.78, reflecting losses generated across the asset base. Inventory turnover of 2.27 indicates how many times Greenway Greenhouse Cannabis Corporation sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Greenway Greenhouse Cannabis Corporation's stock has declined approximately 52.82% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.12.

Over the twelve months ended June 30, 2026, Greenway Greenhouse Cannabis Corporation generated 5.68M in revenue and converted that into -2.15M in net income, yielding earnings per share of -0.02. EBITDA reached -41,615.41, while operating income came in at -1.36M.

As of June 30, 2026, Greenway Greenhouse Cannabis Corporation holds 798,478.73 in cash and equivalents against 10.94M in total debt, resulting in a net debt position of 4.66M. Total book value stands at 5.03M, with working capital of -4.94M providing operational flexibility.

Greenway Greenhouse Cannabis Corporation produced -684,852.84 in operating cash flow over the twelve months ended June 30, 2026. After subtracting -61,193.20 in capital expenditures, free cash flow totaled -746,046.04 - equivalent to -0.01 per share.

Over the twelve months ended June 30, 2026, Greenway Greenhouse Cannabis Corporation posted a gross margin of 6.99, reflecting its pricing power and cost economics. The operating margin of -23.90 and net profit margin of -37.91 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -5.51: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.

As of June 30, 2026, Greenway Greenhouse Cannabis Corporation has an Altman Z-Score of -0.78, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.